Share on Google Plus 1 Share on Twitter 1 Share on Facebook 1 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend (3 Shares)  
Printer Friendly Page Save As Favorite View Favorites (# of views)   4 comments

Exclusive to OpEdNews:
OpEdNews Op Eds

Drug Industry Attacks Bioidentical Hormones Again

By   Follow Me on Twitter     Message Jeffrey Dach     Permalink
      (Page 1 of 2 pages)
Related Topic(s): ; ; ; ; ; ; , Add Tags Add to My Group(s)

Must Read 1   Valuable 1  
View Ratings | Rate It

opednews.com

Author 30652
Become a Fan
  (13 fans)
- Advertisement -
Image: Abandoning the Sinking Ship courtesy of wikimedia commons.

Just when things have calmed down, the drug industry opens a new salvo in its war against bioidentical hormones, perceived as stealing market share from their women's hormone pill, Prempro, currently in litigation for causing cancer and heart disease.

The attack article appeared in the Huffington Post by Phyllis Greenberger, CEO of Society for Women's Health Research (SWHR), an industry-sponsored mouthpiece that funnels money from the drug industry to doctors for research grants, speaking engagements, meetings and even gala celebrations.

Hot Flash and Cold Cash by Alicia Mundy

A 2003 expose by Alicia Mundy in the Washington Monthly discloses SWHR-industry ties to Eli Lilly, Johnson & Johnson, Merck, Pfizer, and Wyeth, companies sitting on the SWHR advisory board.

Serving Your Corporate Master

Apparently, having the drug industry as one's corporate master requires regurgitation of old marketing propaganda, even if it doesn't make sense. Even to the most casual observer, this Huffington Post piece is a blatant attempt to discredit bioidentical hormones using fallacies, innuendo, and misinformation. Much of this material was covered in my free book, Bioidentical Hormones 101.

Let's Take A Look At the Huff Post Article

The author, Phyllis Greenberger M.S.W., states, "Bioidentical hormones are not FDA approved."

- Advertisement -

This is blatantly incorrect. There are twenty or so FDA-approved bioidentical-hormone preparations widely available at corner drug stores. Here are a few examples: Vivelle-Dot, Estrace, Climara, Prometrium, Androgel, etc.

The author Phyllis Greenberger states: "Bioidentical hormones made by compounding pharmacies are non-FDA approved."

This is misleading and deceptive. Compounding pharmacies are regulated at the state level, and do not fall under FDA jurisdiction. So, of course compounding is not FDA approved. No FDA approval is required or even desired. Your local hospital pharmacy is a compounding pharmacy that makes up life-saving medication such as IV antibiotics with no FDA oversight or approval. The FDA-approval process is designed for manufacturer capsules and tablets, and is impractical and unnecessary for compounded medications prepared to order by hand. Are we going to reject IV antibiotics from the hospital pharmacy because these are non-FDA approved compounded medication? Of course not. Compounding is here to stay.

Preventing Endometrial Cancer

The author, Phyllis Greenberger, brings up a 2007 report of three cases of endometrial cancer in women on bioidentical hormones, implying that synthetic PremPro prevents endometrial cancer whereas biodentical hormones do not. This is a blatant lie.

- Advertisement -

Prempro contains a synthetic progestin that reduces the incidence of endometrial cancer. However, this is not reduced to zero. The author conveniently neglected to mention the 66 cases of endometrial cancer in Prempro-treated women as reported by Dr. Chlebowski. Examining the Women's Health Initiative data after 13.2 years of follow-up, there were 66 endometrial cancers among women given synthetic PremPro (premarin and medroxyprogesterone).

Another fact conveniently omitted by the article: The bioidentical hormone, progesterone, has been studied and is FDA approved for prevention of endometrial hyperplasia. Preventing endometrial hyperplasia is the best way to prevent endometrial cancer, and a major reason why progesterone is always included in a bioidentical-hormone program.

A "Bad Drug" in Litigation?

One easy way to determine if you are dealing with a "bad drug" is to ask the question: Is this a drug in litigation? For Prempro and synthetic "FDA-approved" women's hormones, the answer is yes; Prempro has been in litigation for years now. Pfizer, the company that bought Wyeth, has paid almost a billion dollars to settle 6,000 lawsuits by women who claimed the drug caused their breast cancer. This information should have been included, yet was conveniently omitted from the Huffington Post article by Phyllis Greenberger.

A Quote from June 19, 2012 Bloomberg News:

Next Page  1  |  2

 

- Advertisement -

Must Read 1   Valuable 1  
View Ratings | Rate It

http://jeffreydachmd.com
Jeffrey Dach MD is a physician and author of two books, Natural Medicine 101, and Bioidentical Hormones 101, both available on Amazon, or as a free e-book on his web sites. Dr. Dach is founder and chief medical officer of TrueMedMD, a clinic in (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon


Go To Commenting

The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Follow Me on Twitter

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Failed Hatchet Job on Larry King, Suzanne Somers, Knockout

Bioidentical Hormones on Oprah, Are They Safe?

Why Natural Thyroid is Better than Synthetic

Wheatgrass, Natural Medicine in the Kitchen

Fish Oil Increases Risk for Prostate Cancer, New Study?

Spontaneous Remission Cancer Breakthrough